GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit After Tax | ₹-1,831 Cr | ₹-90 Cr | ₹994 Cr | ₹970 Cr | ₹776 Cr |
What is the latest Profit After Tax of GLENMARK PHARMACEUTICALS ?
Year | Profit After Tax |
---|---|
Mar2025 | ₹-1,831 Cr |
Mar2024 | ₹-90 Cr |
Mar2023 | ₹994 Cr |
Mar2022 | ₹970 Cr |
Mar2021 | ₹776 Cr |
How is Profit After Tax of GLENMARK PHARMACEUTICALS Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹-1,831 Cr | Negative | |
Mar2024 | ₹-90 Cr | Negative | |
Mar2023 | ₹994 Cr | 2.43 | |
Mar2022 | ₹970 Cr | 25.02 | |
Mar2021 | ₹776 Cr | - |
Compare Profit After Tax of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹60,146.7 Cr | 7.1% | 5.6% | 24.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 7.1% |
5.6% |
24.3% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses